Overview

Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia

Status:
Completed
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
A randomized trial of olanzapine and Long-acting paliperidone palmitate injection in the treatment of 100 treatment- naive first-episode patients with schizophrenia.
Phase:
N/A
Details
Lead Sponsor:
Beijing HuiLongGuan Hospital
Collaborator:
WenZhou-Kangning Hospital
Treatments:
Olanzapine
Paliperidone Palmitate